Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy
ADENOCARCINOMA DE JUNÇÃO ESOFAGOGÁSTRICA COM SUPEREXPRESSÃO DO HER 2 EM PACIENTE COM MIELOMA MÚLTIPLO: RELATO DE UMA RARA ASSOCIAÇÃO
F.M. Carlotto, J. Pastorello, D.R. Almeida
10.1016/j.htct.2020.10.414
Hematol Transfus Cell Ther. 2020;42 Supl 2:247
Open access
Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study
E. Terpos, A. Symeonidis, S. Delimpasi, E. Zamagni, E. Katodritou, E. Rivolti, M. Kyrtsonis, D. Fotiou, N. Kanellias, M. Migkou, M. Roussou, M. Gavriatopoulou, E. Hatjiharissi, M. Cavo, M. Dimopoulos
10.1016/j.htct.2020.09.043
Hematol Transfus Cell Ther. 2020;42 Supl 1:22-3
Open access
COVID-19 infection in cancer patients: a systematic review and meta-analysis with emphasizing the risk and prognosis stratification
G. Elgohary
10.1016/j.htct.2020.09.046
Hematol Transfus Cell Ther. 2020;42 Supl 1:24-5
Open access
Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19
N. Yarali, Y. Akcabelen, Y. Unal, A. Ozkaya-Parlakay
10.1016/j.htct.2020.09.051
Hematol Transfus Cell Ther. 2020;42 Supl 1:27
Open access
Acute ischemic stroke presentation of otherwise asymptomatic covid-19 patient
E. Aksoy, Y. Tor, S. Kalayoglu Besisik, A. Alibeyoglu, M. Kose, N. Senkal, A. Cagatay, M. Erelel, T. Tukek
10.1016/j.htct.2020.09.082
Hematol Transfus Cell Ther. 2020;42 Supl 1:46
Open access
Hepcidin level changes in type 2 diabetes
A. Gawaly, F. Atyia
10.1016/j.htct.2020.09.102
Hematol Transfus Cell Ther. 2020;42 Supl 1:57
Open access
Reactive lymphocytes in blood film of a covid-19 iraqi patient: a case report
A. Al-Ani
10.1016/j.htct.2020.09.104
Hematol Transfus Cell Ther. 2020;42 Supl 1:57-8
Open access
A study of hematological disease prevalence in covid-19 pandemic: a single center experience
V. Gursoy
10.1016/j.htct.2020.09.105
Hematol Transfus Cell Ther. 2020;42 Supl 1:58
Open access
Hematologic manifestations associated with deficiency of adenosine deaminase 2 and a novel ada2 variant
E. Hanafy, M. Al Twaijri, N. Al Bolowi
10.1016/j.htct.2020.09.135
Hematol Transfus Cell Ther. 2020;42 Supl 1:75
Open access
COVID-19 in hematology: data from a hematologic and transplant unit
Marcia Garnica, Marcia Rejane Valetim, Paulo Furtado, Maria Claudia Moreira, Ricardo Bigni, Simone Vinhas, Paulo Cesar Dias, Ilza Fellows, Wolney Martins
10.1016/j.htct.2020.08.004
Hematol Transfus Cell Ther. 2020;42:293-9
Open access
Open Article
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.